首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Curcumin and long-chain Omega-3 polyunsaturated fatty acids for Prevention of type 2 Diabetes (COP-D): study protocol for a randomised controlled trial
【2h】

Curcumin and long-chain Omega-3 polyunsaturated fatty acids for Prevention of type 2 Diabetes (COP-D): study protocol for a randomised controlled trial

机译:姜黄素和长链Omega-3多不饱和脂肪酸预防2型糖尿病(COP-D):一项随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundLifestyle interventions, including increase in physical activity and dietary counselling, have shown the ability to prevent type 2 diabetes (T2D) in high-risk state individuals, but the prevalence is still skyrocketing in Australia, in line with global prevalence. Currently, no medicines are approved by the Therapeutic Goods Administration in Australia for the management of prediabetes. Therefore, there is a need of developing a safer, biologically efficacious and cost-effective alternative for delaying the transition of individual health state from prediabetes into T2D. In the current trial we propose to evaluate the effects of curcumin and/or long-chain omega-3 polyunsaturated fatty acids on improving glycosylated haemoglobin as a primary outcome, along with secondary outcomes of glycaemic indices, lipid profile and inflammatory parameters.
机译:背景生活方式的干预措施,包括增加体育锻炼和饮食咨询,已显示出可以预防高危州人群的2型糖尿病(T2D),但在澳大利亚,这种流行率仍在飙升,与全球流行率一致。目前,澳大利亚治疗用品管理局尚未批准用于治疗糖尿病前期的药物。因此,需要开发一种更安全,生物学上有效且具有成本效益的替代方案,以延迟个体健康状况从糖尿病前期向T2D的转变。在本试验中,我们建议评估姜黄素和/或长链omega-3多不饱和脂肪酸对改善糖基化血红蛋白的主要作用,以及血糖指数,脂质分布和炎性参数的次要结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号